Because previous studies have shown that TLR9 activation exerts protective effects against the development of colitis [20], [21] we have investigated whether TLR9 activation by in vivo administration of CpG rescues FXR−/− mice from colitis induced by TNBS administration. Here, TLR9 is linked to colitis.